Related Experiment Video
Updated: Aug 22, 2025
03:53
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
887
Tissue Factor, Thrombosis, and Chronic Kidney Disease
Yuji Oe1,2,3, Nobuyuki Takahashi4
1Division of Nephrology, Rheumatology, and Endocrinology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Biomedicines
|November 11, 2022
Summary
Chronic kidney disease (CKD) involves coagulation issues. Tissue factor (TF) activation by uremic toxins worsens kidney injury and thrombotic risk, accelerating CKD progression.
Area of Science:
- Nephrology
- Hematology
- Biochemistry
Background:
- Coagulation abnormalities are prevalent in chronic kidney disease (CKD).
- Tissue factor (TF) initiates the extrinsic coagulation cascade, leading to fibrin formation.
- TF and its downstream proteases activate protease-activated receptors (PARs), contributing to organ injury.
Purpose of the Study:
- To review recent research on the role of TF in thrombotic risk and CKD progression.
- To elucidate mechanisms linking CKD-specific conditions to increased thrombotic tendency.
Main Methods:
- Review of recent scientific literature.
- Analysis of studies investigating TF activation and its downstream effects in CKD.
- Examination of the impact of uremic toxins on the TF pathway.
Main Results:
- Uremic toxins like indoxyl sulfate and kynurenine accumulate in CKD, activating TF and coagulation.
- The TF-coagulation protease-PAR pathway exacerbates renal inflammation and fibrosis.
- These pathways contribute to increased thrombotic risk and disease progression in CKD.
Conclusions:
- TF plays a critical role in promoting thrombotic risk in CKD.
- The TF-coagulation protease-PAR axis is a key driver of renal injury and fibrosis in CKD.
- Targeting TF may offer therapeutic strategies for managing CKD progression and associated complications.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
838
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
838
01:25Chronic Kidney Disease I: Introduction
56
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56
01:30Venous Thrombosis I: Introduction
26
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
26
01:24Disorders of Hemostasis
1.1K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.1K
01:24Chronic Kidney Disease II: Clinical Manifestations
62
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
62
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.8K